News & Events

Underground Recovery Awarded Patent for Carbon-Free Coal Combustion Process


Underground Recovery, LLC, a company based at UK's Coldstream Research Campus in Lexington, KY, has been awarded a patent for its revolutionary carbon-free coal combustion process. 
 
Lexington, KY, July 24, 2014 – Coal has been, is, and will remain one of the most abundant fossil fuels in the world, especially in the United States, and particularly in Kentucky. As of 2012, coal generates 41% of the world’s electricity, and in 2013, coal generated 93% of all Kentucky’s electricity. Kentucky is the third largest producer of coal in the US, and one of the largest exporters of coal to Asian markets. Despite its benefits, coal mining and combustion have historically presented an environmental threat, producing undesirable carbon dioxide emissions, greenhouse gas emissions, and ash.
 
Founded in 2011, Underground Recovery, LLC — a Lexington-based research and development company devoted to environmentally friendly and cost effective recovery of energy and metals from underground resources — was granted a US patent (US 8,776,518 B1) on July 15, 2014 for its innovative coal combustion process, which can eliminate atmospheric release of carbon dioxide emissions and ash. This new process may be a tremendous boon to coal industries in Kentucky and throughout the world, as it provides an economically feasible alternative to the current process of coal mining, followed by above ground combustion and power generation with subsequent underground carbon sequestration. 
 
Underground Recovery was founded by Dr. Subodh Das in 2011. Dr. Das is a scientist, engineer, and inventor with over 20 US patents, largely renowned for his work in the aluminum industry. He is the founder and CEO of Phinix, LLC, an international research and development company serving the aluminum, magnesium and titanium metals and scrap industries. Previously, Dr. Das has served on the boards of The Aluminum Association, SECAT, Inc., Commerce Lexington and the Minerals, Metals and Materials Society. The American Society of Metals elected him an ASM Fellow in 2002. The Minerals, Metals and Materials Society also awarded Dr. Das its prestigious Distinguished Service Award in 2001. Additionally, he was awarded the JOM Best Paper Award in 2011.
 
Underground Recovery, LLC is currently applying for state and federal grants, and approaching private investors to demonstrate the proof of concept for this new technology.
 

Equinext and Centaur Animal Health Enter Distribution Agreement for Innovative Equine Medical Device Novobrace


Novobrace logo

 

Novobrace, an injectable bioadhesive, stabilizes equine tendon and ligament injuries, including tendonitis.

 

LEXINGTON, KY & OLATHE, KS & PHILADELPHIA, PA, June 24, 2014 –
 
Equinext and Centaur Animal Health today announced that they have entered into an exclusive distribution agreement for Equinext’s Novobrace product. Centaur Animal Health will place Novobrace in the equine veterinary market as a treatment for injured tendons and ligaments, including tendonitis.
 
"We believe that the introduction of Novobrace into the equine market to treat the difficult problem of soft tissue tendon and ligament injuries including tendonitis will serve to provide a major advancement in equine recovery and rehabilitation of the difficult to treat injuries which sidelined ”I’ll Have Another” in last year’s Belmont Stakes. Novobrace’s clinical results show efficacy as an injectable stabilizer in both a standalone treatment and complementary therapy option for veterinarians using regenerative treatments including stem cells. “Novobrace is equivalent to a cast in bone injuries but unlike bone casts is flexible and elastic; perfectly designed to soft tissue injuries” states Eric Hauck, Equinext CEO and Founder. Novobrace significantly reduces healing time, helps to prevent further injury during recovery and enables the horse to maintain fitness and freedom from stall confinement while recovering.
 

Novobrace

“We are extremely pleased that Centaur and Equinext share a common vision in equine health to bring this technology to horses that without treatment often have a career ending soft tissue injuries. This agreement to distribute Novobrace in North America will quickly improve equine and companion animal health," shared Jeff Boily, President & CEO, Centaur Animal Health. “We are excited to see this partnership come to fruition and believe that with Centaur’s help we will make this technology widely available in the US,” Boily further stated. This technology has been made possible by the work of many here in the Horse Capital of the World, Lexington KY. “These include the Bluegrass Angel Investment Fund II, the Commonwealth Capital Seed Fund and KY Enterprise Fund,” stated Hauck.
 
Novobrace has been evaluated and tested by leading veterinarians across the USA and the outcomes far surpass the expectations of treating clinicians. Internationally recognized veterinarian, Reese Hand, DVM, DACVS, of Equine Sports Medicine and Surgery, Weatherford, Texas, an early adopter of the technology spoke recently of his treatment outcomes in 22 horses to date, all of whom have returned faster and stronger to their respective training regimens. “I have used the Novobrace on more than 20 horses to date. The early results are impressive. Novobrace does what it states it will do: provides an internal brace to stabilize the lesion so healing can occur more rapidly. I am excited about what this technology offers our industry.”
 
About Novobrace
Our patented technology, NEXT, is a chemically made internal brace formed by injection of a crosslinking agent which immediately adds mechanical support to the tendon or ligament. This brace prevents further propagation of the lesion, provides better, stronger healing, and results in the horse returning to full work
significantly faster. Novobrace may be used as a standalone treatment or as a complementary therapy. Clinical indications include the treatment of superficial digital tendons, deep digital flexor tendons and suspensory ligaments with or without lesion. For more information http://www.equinext.net
 
About Equinext LLC
Equinext is a spinoff company of Orthopeutics with offices and laboratory on the University of Kentucky’s Coldstream Research Campus in Lexington, Ky. Equinext is affiliated with Coldstream Research Campus of the University of Kentucky, University of Kentucky Enterprise Fund, Commonwealth Seed Capital Fund, ,
Equine Sports Medicine and Surgery (Weatherford, TX), Duncan Peters DVM, MS, DACVSMR formally of Hagyard Equine Medical Institute and currently with the Michigan State University., and Kentucky Science & Technology Corporation. For more information http://www.equinext.net
 
About Centaur Animal Health
Centaur Animal Health was founded in 1986 and is focused on developing innovative diagnostics, pharmaceuticals and nutraceuticals that address significant therapeutic needs for companion and production animals. Centaur licenses and develops patent-protected technologies from animal health or human
pharmaceutical and biotechnology companies. Custom manufacturing is available in their FDA and DEA certified plant. For more information, please visit www.centauranimalhealth.com
 
 
Equinext and Novobrace are registered trademarks of Equinext LLC. Other trademarks are owned by their respective companies.

Patent reform could stifle innovation, high-tech startups


Published May 27, 2014 in the Lexington Herald-Leader
By George Ward
 
The U.S. patent system has been under intense scrutiny lately by federal and state lawmakers, as proposed reforms threaten to weaken our patent system, a system upon which countless innovators have relied for more than 200 years.
 
It is important that any action taken by lawmakers does not unintentionally stifle commercialization and innovation.
 
Proponents to changes in patent law are companies that have been victimized by the so-called "patent trolls." They are patent owners that do not design or manufacture products or processes, sometimes referred to as "nonpracticing entities."
 
Patent trolls instead threaten legal action against companies using routine business technologies such as providing free Wi-Fi in a store or placing the "shopping cart" feature on a website.
 
I am concerned that some provisions in these legislative proposals are drafted in an overly broad manner and go far beyond what is necessary in targeting bad actors within the industry. While abusive patent litigation is unwanted behavior, small high-tech companies could be harmed by new legislation that weakens their ability to defend patents on new technologies they develop.
 
As recognized in a recent article written by Brian W. Hannon and Margaret M. Welsh, of Sughrue Mion PLLC, not all nonpracticing entities are alike; they "may include universities, startups, technology transfer offices and research institutions."
 
As executive director for the University of Kentucky's Coldstream Research Campus, I see firsthand how difficult and time-consuming the process is for bringing inventions to the market — a process that sometimes stalls for a period due to unexpected gaps in funding.
 
UK provides support to more than 25 very early-stage companies still in their research and development stage. Many of these companies are further developing innovations first made in the labs at UK. These companies are the innovative product and well-paying job creators of the future. Any acts by lawmakers that impede small technology companies from prosecuting and protecting the patent rights they hold could not only reduce the number of new discoveries and new products that will make our lives better in the future, but harm the future jobs and the economy of our commonwealth.
 
Every era of invention has seen an increase in attention surrounding patents, mainly because of the surge of lawsuits that historically accompany the really big discoveries.
 
Patent wars have in fact been a hallmark of the system, dating all the way back to the discovery of the sewing machine in the 1850s and for other discoveries including light bulbs, telephones and automobiles.
 
In each case, litigation eventually subsided, technology evolved and our lives were made richer.
 
Adam Mossoff, in his article, "The Sewing Machine Patent Wars," stated:
 
"The patent litigation rate between 2000 and 2010 was a constant 1.5 percent. As reported by award-winning economist Zorina Khan, the average patent litigation rate between 1790 and 1860 was 1.65 percent ... Also, it bears noting that the measurable increase in patent litigation in 2012 was entirely the result of legal changes to the patent system instituted by the America Invents Act of 2011, as recognized by Congress' GAO Report on Patent Litigation (August 2013)."
 
It is critical that the Senate Judiciary Committee listen to all sides of this debate before rushing to action. I firmly believe a reasonable compromise that protects the rights of innovators while combating harmful patent prac tices is attainable if a robust debate examines the pros and cons of each proposed change.
 
To overcompensate for the trolls without seeing a bigger picture that supports innovation could undercut our ability to improve lives, grow jobs and compete on a global scale.

Tempur Sealy announces acquisition of Sealy brand rights In Japan


Tempur Sealy
 
 
LEXINGTON, Ky. (April 8, 2014) — Tempur Sealy International, Inc. (NYSE: TPX), the world’s largest bedding provider, has signed a definitive agreement to acquire the Sealy brand rights in Japan and certain assets from its former licensee. The company anticipates closing the transaction, which is subject to customary closing conditions, during its fiscal third quarter of 2014. Financial terms were not disclosed.
 
As part of the transaction, certain functions of the former licensee, including sales and marketing, will be integrated into the company’s Japanese subsidiary. In addition, the companies have executed a supply agreement, whereby the former licensee will become a contract manufacturer for certain Sealy branded products in Japan.
 
“New market expansion is one of our four key strategic growth initiatives and is also an important driver in our long-term international revenue synergies targets. The acquisition of Sealy brand rights in Japan is the first transaction whereby we have regained rights from a Sealy licensee arrangement,” said Tempur Sealy International, Inc. CEO Mark Sarvary. “Japan has been an important market for our company for a long time and we are excited at the prospects of further increasing our penetration and market share with a strengthened brand and product offering.”
 
Chief Financial Officer Dale Williams said, “As a result of this transaction, we anticipate Japan will soon be our largest market as measured by sales outside of North America. Given our current expectation for when the deal will close, we anticipate the transaction will be break-even to modestly accretive to earnings in 2014 and accretive thereafter.”

April 2014 StreamLines Newsletter


newsletter header

 

The April 2014 StreamLines Newsletter can be found online here.

 

In This Issue:

HDI Seminar on Facilitating Access for Students with Limited Communication Skills


LEXINGTON, Ky. (Jan. 16, 2014) — The Human Development Institute at the University of Kentucky (HDI) will present a free seminar about facilitating access for students with complex communication needs. 
 
“Communication First: Facilitating Access to the General Curriculum,” will be presented from 1-3 p.m. EST (noon -2 p.m. CST) Thursday, Feb. 27,  in the Human Development Training Room at UK's Coldstream Research Campus. Video-conference sites will be available around the city and at locations throughout the state.
 
All students communicate, although sometimes in very subtle behaviors that can be easily missed or in challenging behaviors that are quite obvious but fail to communicate to their educators, peers or parents. Evidence-based practice has found that, with direct instruction and augmentative communication most suited to their needs, students can gain communicative competence at a rapid rate.
 
Presenting will be Jacqueline Kearns, principal investigator of HDI's Teaching Age Appropriate Learning Through Communication (TAALC) Project, and Judith Page, associate professor in the Division of Communication Disorders in the UK College of Health Sciences.
 
Space is limited and registration is required. Those who wish to attend may register online. Attendance site must be selected at time of registration; if a site is full, you will have the option to select another site. HDI's seminar series is open to faculty, staff and students, as well as self-advocates, parents/caregivers and professionals statewide.
 
Continuing education units (CEUs) are approved for effective instructional leaders and social work, psychology and licensed professional counselors. The seminar is affiliated with the Kentucky Office of Vocational Rehabilitation for CEUs in Certified Rehabilitation Counseling. There is a $20 CEU fee for social workers, psychologists and licensed professional counselors.
 
If you wish to host a live video-conference for your community at your site, please contact Patti Naber Singleton, 859-257-4913. For general questions about the HDI Seminar Series, please contact Tina Lindon, 859-257-1714.
 
 
MEDIA CONTACT: Keith Hautala, 859-323-2396

New KNODE Portal Connects UK Researchers with Potential Collaborators


LEXINGTON, Ky. (Jan. 9, 2013) — The University of Kentucky is partnering with KNODE Inc. to promote and connect UK researchers with colleagues and potential collaborators worldwide.
 
Through a UK-specific portal, the KNODE platform helps individual researchers, academic institutions and companies share scientific knowledge, particularly in the biomedical field.
 
Anyone can create a free login to access UK’s portal and/or search the complete database that currently includes millions of researchers worldwide. Users can search by expert name, area of expertise or affiliation, with search results linking to next-generation expertise profiles automatically generated by KNODE’s advanced semantic mining and data processing algorithms.
 
Users can dynamically search and filter an expert’s scientific content (publications, patents, grants, and clinical trials), aggregated by KNODE’s platform from publically available databases (PubMed, USPTO, NIH RePORTER, clinicaltrials.gov). Researchers with profiles in the system can also claim and edit their information, add links to university lab pages and make other enhancements.
 
"KNODE provides us a single, searchable gateway to the leading-edge biomedical research being conducted by our investigators and our collaborators in industry and academia," said UK Vice President for Research James W. Tracy. "Technology like this can spur vital scientific collaboration."
 
David Steinberg, KNODE's acting chief executive officer and partner at Boston-based PureTech Ventures, said, "There is a clear opportunity to develop exciting ways to automate and characterize researcher expertise, while also making these experts searchable and accessible in a new, powerful way. We are pleased to be working with the University of Kentucky to put their researchers and collaborators in the spotlight, highlighting their unique capabilities and scientific track record.”
 
In addition to adding the University of Kentucky to its growing list of academic partnerships, KNODE also recently announced a commercial partnership with Wiley, a leading international scientific publisher. The company also has formed partnerships with AstraZeneca and others to improve life sciences R&D efforts such as technology licensing and collaboration. KNODE is part of Enlight Biosciences LLC, created by PureTech Ventures in partnership with major pharmaceutical companies and academic supporters.
 
For more information on UK’s KNODE portal, visit http://www.research.uky.edu/knode.
 
MEDIA CONTACT:  Keith Hautala, 859-323-2396 or keith.hautala@uky.edu

CBRE Cincinnati to Represent Proposed Data Center on the Coldstream Research Campus


November 18, 2013 
         
LEXINGTON, KY– Mike McMillan of CBRE Cincinnati's Data Center Solutions Group is representing KDC Real Estate Development & Investments' data center build-to-suit site located at the University of Kentucky's Coldstream Research Campus in Lexington, Kentucky.
 
Once pre-leasing reaches 20,000 square feet, the proposed data center site will be located on the beautiful 735-acre campus that is minutes away from UK and downtown Lexington. The Coldstream Research Campus is currently home to 66 organizations with more than 2,000 employees working in biotechnology, pharmaceuticals and equine health, and a variety of other industry sectors.
 
The proposed data center will not only support local businesses’ IT and computing needs but will also help the local community.
 
“Building a data center at this site will give local Lexington businesses a secure, flexible and scalable place for their computer equipment,” Mike McMillan, of the CBRE Data Center Solutions Group, said. “It will support new businesses looking to move to Lexington and also bring new jobs to the community.”
 
It will also save businesses' time and money because they won’t have to design, build and manage their own data center, McMillan said.
 
 
For more information, contact:
  
Mike McMillan | Vice President
CBRE | Data Solutions Group
T +1 513 369 1306
 
 
Joe Ludwig | Communication Specialist
CBRE | Americas Marketing
T +1 513 369 1305

Hummingbird Nano Inc. Highlighted in National Report by The Science Coalition


LEXINGTON, Ky. (Oct. 29, 2013) — A University of Kentucky spin-off company is among those highlighted in a new national report released today by The Science Coalition.
 
Hummingbird Nano Inc., a high-tech startup based at UK's Coldstream Research Campus, is featured in “Sparking Economic Growth 2.0: Companies Created from Federally Funded Research, Fueling American Innovation and Economic Growth.” The report identifies 100 companies that trace their roots to federally funded university research. These companies, while only a tiny fraction of the new companies formed each year, are contributing to the U.S. economy in a significant way.
 
"Every dollar of federal funds that is invested in research returns many dollars more, both in terms of immediate economic activity and in long-term dividends," said James W. Tracy, UK vice president for research. "It is critical to the economic health of Kentucky, and of the United States, that our nation continues to invest strongly in the basic research that leads to innovation and job creation."
 
In fiscal year 2013, external research grants and contracts contributed $367.1 million to the Kentucky economy, including $194.4 million in personal income. Externally supported research accounted for 9,427 jobs at UK and throughout Kentucky. Each dollar of out-of-state external funding for research generates approximately $1.90 of total related expenditures.
 
The basic scientific research that gives rise to companies like Hummingbird Nano, and spurs the economy in many other ways, is jeopardized by the current funding environment, Tracy said. Federal funding for research and development has been on a downward trend for the past decade, with funding levels in 2013 at historic lows. 
 
Sequestration, which began in March 2013, is set to run through 2021 and will wring an additional $95 billion from federal research budgets over this period. This national disinvestment in science will have real consequences. As the Sparking Economic Growth 2.0 companies illustrate, research and the transformative discoveries that flow from it often require sustained funding over many years to yield results.
 
Hummingbird Nano is an example. The initial research that led to the company's founding was undertaken at UK with approximately $300,000 in funding from the National Science Foundation and the Department of Education. From 2000-2007, researchers worked to develop a new manufacturing system that maintains extreme tolerances and precision to mass produce micro-sized molded plastic and glass parts. The technology was further developed for commercialization for another five years, from 2007-2012, under the auspices of Hummingbird's predecessor company, AMT Nano LLC.
 
The September 2012 launch of Hummingbird Nano signaled a transition from research and development to a commercial enterprise centered on precision-molded components for the telecommunications, biotechnology, aerospace, energy and defense industries.
 
“The basic research into the limitations of existing machinery revealed the direction for new processes and machines," said L. Scott Stephens, chair of the UK Department of Mechanical Engineering and Hummingbird co-founder. "The result is a manufacturing system for the mass production of micro-sized parts and assemblies with unparalleled precision. Our technology enables products that could not be produced economically before to be produced in quantities exceeding 100 million annually."
 
University research and the companies born from such research are a driving force behind much of the innovation in the United States. They are bringing forward innovations with the potential to transform industries and solve some of the world’s greatest problems. Since industry conducts relatively little basic research today (about 20 percent), the “seed corn” produced at research universities is essential to U.S. industry and its ability to compete.
 
Research universities like UK play an important role in the creation and future success of spin-off companies, providing a nurturing environment and critical assistance to researcher-entrepreneurs aiming to bring research discoveries to the marketplace. 
 
"UK has successfully fostered new companies and emerging technologies through our business incubator the Advanced Science & Technology Commercialization Center, better known as ASTeCC," Tracy said.
 
Forty-three companies have "graduated" from ASTeCC since 1994. For companies that have outgrown ASTeCC, UK subleases larger laboratory and office spaces or assists with identifying available locations for lease in privately owned buildings at the Coldstream Research Campus. Hummingbird Nano is just one of 66 organizations at Coldstream, where more than 2,000 employees work in biotechnology, pharmaceuticals, equine health and a variety of other industry sectors.
 
The Science Coalition is a nonprofit, nonpartisan organization of more than 50 of the nation’s leading public and private research universities, including UK. It is dedicated to sustaining the federal government’s investment in basic scientific research as a means to stimulate the economy, spur innovation and drive America’s global competitiveness.
 
The new Science Coalition report is available at www.sciencecoalition.org/successstories. An accompanying database provides access to company profiles and allows users to sort companies by federal funding agency, university affiliation, type of innovation and other criteria. 
 
MEDIA CONTACT: Keith Hautala, 859-323-2396; keith.hautala@uky.edu

ARPA-E Announces $608,863 Award to Phinx LLC for its Transformational Energy Research Project


Phinix LLC One of 33 Technologies in 18 States Working to Secure America’s Energy Future in Advanced Manufacturing  
 
Lexington, KY (October 9, 2013) — On September 19, 2013, Deputy Director Cheryl Martin announced that 33 breakthrough energy projects will receive approximately $66 million from the Advanced Research Projects Agency-Energy (ARPA-E) under two new programs that provide options for a more sustainable and secure American future.  One recipient, Lexington, KY based Phinix, LLC, has been awarded $608,863 for their project titled “Electrochemical Extraction of High Quality Magnesium from Scrap”. Phinix is located at the Coldstream Research Campus.
 
Phinix will develop a new electrochemical cell technology that can recover high-quality magnesium from aluminum-magnesium scrap.  This technology could lower costs, energy inputs, and emissions from magnesium production, expanding its use in transportation industries.  By recovering and reusing aluminum-magnesium scrap, Phinix’s technology could reduce the need for manufacturing new, expensive primary metals while developing a sustainable and low-cost advanced manufacturing process. 
 
Processing of aluminum-magnesium scarp to produce aluminum products used in beverage and transportation sectors is a key market driver for Kentucky’s economically significant aluminum industry employing over 15,000 men and women with high paying jobs.  
 
Deputy Director Martin made the project announcement during a roundtable discussion on Capitol Hill that focused on how American ingenuity and strategic public-private partnerships are driving U.S. energy innovation. 
 
Dr. Subodh Das will the Principal Investigator for this project. 
 
Contact:
Dr. Subodh Das, CEO and Founder
Phinix, LLC
859-619-8386 
 
Syndicate content